Bladder cancer Board decisions

The Veteran's claim for service connection for gastric cancer, non-Hodgkin's lymphoma, and bladder cancer is being remanded due to the need for clarification of his medical opinions regarding exposure at Camp Lejeune.

The Board has remanded the case due to incomplete service records and will consider ACDUTRA/INACDUTRA service in addition to active duty.

The Veteran's cause of death was listed as bladder cancer, but the Board found that his prostate cancer also contributed to his death. The Board granted service connection for the cause of death due to the presumed link between Agent Orange exposure and prostate cancer.

The Veteran's appeal is being remanded for further development, including obtaining VA treatment records and scheduling a VA examination to assess the severity of his service-connected heart disease and any new-onset kidney, colon, and bladder cancer. The issues of TDIU and special monthly compensation at the housebound rate are also inextricably intertwined with these claims.

The Veteran seeks service connection for prostate cancer, bladder cancer, colon polyps, and a heart disorder. The Board finds that additional development is necessary due to the lack of evidence regarding his exposure to Agent Orange during his tour of duty aboard the U.S.S. Lynde McCormick.

The Veteran's prostate cancer and bladder cancer are not service-connected due to lack of evidence linking the conditions to his military service. The skin condition is pending as it relates to a different issue.

The Board has remanded the case due to the need for an expert medical opinion regarding whether the Veteran's service-connected disabilities caused or contributed significantly to his death.

The Board has remanded the case due to technical difficulties with a previous hearing and requests for a new videoconference hearing.

The Veteran's service-connected prostate cancer does not result in any residuals that would warrant a compensable rating. The Board found that the Veteran's urinary symptoms are more likely related to his bladder cancer and subsequent cystoprostatectomy, rather than his prostate cancer.

The Board has determined that additional development is needed to address the Veteran's death and its relationship to his service-connected conditions, including whether any of these conditions were a contributory cause of his death.

The Board has remanded the case for further development to determine if the appellant is recognized as a surviving spouse and to adjudicate the issue of service connection for the cause of the Veteran's death.

The Veteran's bladder cancer claim is being remanded for further development, including obtaining service personnel records to verify his Camp Lejeune service dates and nature of duty. Additionally, VA treatment records from September 2011 to the present are requested.

The Board has remanded the case due to a missed hearing, and no specific rating or effective date is provided.

The Board has remanded the case for additional development to address whether the Veteran's cancer is related to his service in the Persian Gulf and exposure to environmental toxins, including 'dirty sand' and oil well fire smoke.

The appellant withdrew her appeals for several issues, including service connection for dental disability, bladder cancer and nasopharyngeal cancer, and for higher evaluations of cervical disc disease, radiculopathy of the left upper extremity, and radiculopathy of the right upper extremity. The appeal is dismissed.

The Veteran's coronary artery disease is currently rated at 60 percent, and the Board finds that this rating adequately reflects his disability. The evidence does not support a higher evaluation.

The Veteran seeks service connection for bladder cancer, which he claims is due to exposure to contaminated water at Camp Lejeune during his military service. The Board has ordered a new VA examination and requested the Veteran's private treatment records from Dr. R.C.

The Board has denied the Veteran's claims for service connection for prostate cancer and bladder cancer. The preponderance of evidence is against a finding that the Veteran's prostate cancer or bladder cancer are etiologically related to his military service, including any in-service asbestos exposure.

The Veteran's service-connected hearing loss is alleged to have contributed to his death from bladder cancer. The VA has not obtained all necessary records and needs to provide a new opinion on whether the hearing loss played a material causal role in the Veteran's death.

The Veteran seeks service connection for bladder cancer and peripheral neuropathy of the upper and lower extremities. The Board has determined that additional development is needed due to insufficient evidence to decide the claims.